🔗 Visit the ClinicalTrials.gov page for NCT00265018
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. | N Engl J Med | 2010 | 2.97 |
| 2 | ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. | N Engl J Med | 2011 | 2.32 |
| 3 | ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials. | J Clin Oncol | 2013 | 1.44 |
| 4 | An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. | Ann Oncol | 2013 | 0.82 |
| 5 | Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. | Blood | 2016 | 0.77 |